Murray Norris is Director of the Centre for Childhood Cancer Research at the University of New South Wales and Deputy Director of the Children’s Cancer Institute Australia. He obtained his bachelor’s degree in biochemistry from the Australian National University and his PhD in 1989 from the University of New South Wales. His lab focusses on developing novel therapies for childhood cancers and he has been responsible for developing and implementing unique technology enabling the early prediction of relapse in children with acute lymphoblastic leukaemia. From 2016-2018 he served as President of the International Advances in Neuroblastoma Research Association and has a strong interest in elucidating the molecular mechanisms behind MYCN-driven tumourigenesis.